# Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

> **NCT00573768** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 271 (actual)

## Conditions studied

- Ankle Sprain

## Interventions

- **DRUG:** Diclofenac diethylamine 2.32% gel
- **DRUG:** Placebo
- **DRUG:** Diclofenac diethylamine 2.32% gel / Placebo

## Key facts

- **NCT ID:** NCT00573768
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2007-12
- **Final completion:** 2008-07
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573768, "Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00573768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*